
Andrew K. Bohaty
Examiner (ID: 11624, Phone: (571)270-1148 , Office: P/1786 )
| Most Active Art Unit | 1786 |
| Art Unit(s) | 1786, 1759, 1796, 1794 |
| Total Applications | 979 |
| Issued Applications | 602 |
| Pending Applications | 94 |
| Abandoned Applications | 318 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18628343
[patent_doc_number] => 20230287205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => DISSOLVABLE SOLID STRUCTURE HAVING FIRST AND SECOND LAYERS
[patent_app_type] => utility
[patent_app_number] => 18/181675
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181675 | DISSOLVABLE SOLID STRUCTURE HAVING FIRST AND SECOND LAYERS | Mar 9, 2023 | Pending |
Array
(
[id] => 19417220
[patent_doc_number] => 20240293343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications
[patent_app_type] => utility
[patent_app_number] => 18/109031
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109031 | Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications | Feb 12, 2023 | Pending |
Array
(
[id] => 18389961
[patent_doc_number] => 20230158179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/989479
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989479 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | Nov 16, 2022 | Abandoned |
Array
(
[id] => 17836269
[patent_doc_number] => 20220273574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/748432
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748432
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748432 | ORGANIC COMPOUNDS | May 18, 2022 | Abandoned |
Array
(
[id] => 17702959
[patent_doc_number] => 20220202965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => RADIOTRACER COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/695810
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695810
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695810 | RADIOTRACER COMPOSITIONS AND METHODS | Mar 14, 2022 | Abandoned |
Array
(
[id] => 17593656
[patent_doc_number] => 20220143229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => RADIO-PHARMACEUTICAL COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/581808
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581808 | RADIO-PHARMACEUTICAL COMPLEXES | Jan 20, 2022 | Abandoned |
Array
(
[id] => 18253444
[patent_doc_number] => 20230080483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => MTORC MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/553409
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553409 | MTORC MODULATORS AND USES THEREOF | Dec 15, 2021 | Pending |
Array
(
[id] => 18253444
[patent_doc_number] => 20230080483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => MTORC MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/553409
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553409 | MTORC MODULATORS AND USES THEREOF | Dec 15, 2021 | Pending |
Array
(
[id] => 17671067
[patent_doc_number] => 20220184234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METABOLIC TARGETING OF LOW GRADE TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/537029
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/537029 | METABOLIC TARGETING OF LOW GRADE TUMORS | Nov 28, 2021 | Abandoned |
Array
(
[id] => 17658456
[patent_doc_number] => 20220178921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/454300
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/454300 | 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF | Nov 9, 2021 | Abandoned |
Array
(
[id] => 16930696
[patent_doc_number] => 20210196585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => BIODEGRADABLE MICROBEADS
[patent_app_type] => utility
[patent_app_number] => 17/199950
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199950 | BIODEGRADABLE MICROBEADS | Mar 11, 2021 | Abandoned |
Array
(
[id] => 18334655
[patent_doc_number] => 20230126603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => WATER-DISPERSIBLE, OIL-FREE, AND UV-BLOCKING COSMETIC COMPOSITION AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/798238
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798238 | WATER-DISPERSIBLE, OIL-FREE, AND UV-BLOCKING COSMETIC COMPOSITION AND PREPARATION METHOD THEREFOR | Feb 8, 2021 | Pending |
Array
(
[id] => 16779410
[patent_doc_number] => 20210116488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors
[patent_app_type] => utility
[patent_app_number] => 17/109010
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109010 | Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors | Nov 30, 2020 | Abandoned |
Array
(
[id] => 17944277
[patent_doc_number] => 20220331294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => GEL-CHEWABLE DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 17/753648
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753648 | GEL-CHEWABLE DOSAGE FORM | Sep 14, 2020 | Pending |
Array
(
[id] => 17850607
[patent_doc_number] => 20220280648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => DESIGN AND EFFICIENT SYNTHESIS OF LIPID-FLUORESCEIN CONJUGATES FOR CAR-T CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/625066
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625066 | DESIGN AND EFFICIENT SYNTHESIS OF LIPID-FLUORESCEIN CONJUGATES FOR CAR-T CELL THERAPY | Jul 1, 2020 | Pending |
Array
(
[id] => 17748305
[patent_doc_number] => 20220226508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/595823
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595823 | METHODS AND COMPOSITIONS FOR TREATING EPILEPSY | May 27, 2020 | Abandoned |
Array
(
[id] => 17805970
[patent_doc_number] => 20220257805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206
[patent_app_type] => utility
[patent_app_number] => 17/613407
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613407 | PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206 | May 19, 2020 | Abandoned |
Array
(
[id] => 16257784
[patent_doc_number] => 20200267159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => INDEX AND METHOD OF USE OF ADAPTED FOOD COMPOSITIONS FOR DYSPHAGIC PERSONS
[patent_app_type] => utility
[patent_app_number] => 16/717175
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717175 | INDEX AND METHOD OF USE OF ADAPTED FOOD COMPOSITIONS FOR DYSPHAGIC PERSONS | Dec 16, 2019 | Abandoned |
Array
(
[id] => 15432131
[patent_doc_number] => 20200030248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL
[patent_app_type] => utility
[patent_app_number] => 16/593141
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/593141 | GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL | Oct 3, 2019 | Abandoned |
Array
(
[id] => 17140275
[patent_doc_number] => 20210308286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => LONG-CIRCULATING PSMA-TARGETED PHOTOTHERANOSTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/264220
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264220 | LONG-CIRCULATING PSMA-TARGETED PHOTOTHERANOSTIC AGENT | Jul 29, 2019 | Abandoned |